SCHEMBL22264064

SCHEMBL22264064

O=C(/C=C/c1ccccc1)c1ccc(Cl)cc1Cl

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.70
NPC1 O15118 1/20 0.62
RAB9A P51151 1/20 0.62
CYP1B1 Q16678 1/20 0.61
EGFR P00533 1/20 0.58
CXCL12 P48061 1/20 0.58
MAOB P27338 5/20 0.57
HDAC4 P56524 1/20 0.57
HDAC1 Q13547 1/20 0.57
MAPT P10636 2/20 0.56
MAOA P21397 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
KDM4E B2RXH2 1/20 0.56
MEN1 O00255 1/20 0.56
ALDH1A1 P00352 1/20 0.56
CYP3A4 P08684 1/20 0.56
THRB P10828 1/20 0.56
HPGD P15428 1/20 0.56
ALOX15 P16050 1/20 0.56
MAPK1 P28482 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29632027 1.00 AR (0.70) ARNPC1RAB9ACYP1B1EGFR
SCHEMBL25197758 0.86 SRD5A2 (0.59) ARNPC1RAB9ACYP1B1CXCL12
SCHEMBL25199493 0.86 SRD5A2 (0.59) ARNPC1RAB9ACYP1B1CXCL12
SCHEMBL25202088 0.86 AR (0.78) ARNPC1RAB9ACYP1B1MAOB
SCHEMBL25266016 0.86 AR (0.78) ARNPC1RAB9ACYP1B1MAOB
SCHEMBL30384316 0.86 AR (0.78) ARNPC1RAB9ACYP1B1MAOB
SCHEMBL25198960 0.86 AR (0.73) ARCXCL12MAOBHDAC4HDAC1
SCHEMBL25219942 0.85 CXCL12 (0.63) ARCYP1B1CXCL12MAOBMAPT
SCHEMBL27890333 0.84 MAPT (0.67) ARCYP1B1MAOBMAPTMAOA
SCHEMBL8987373 0.83 PTGS1 (0.67) ARCYP1B1EGFRCXCL12MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609327-B1 A NEMATICIDAL COMPOSITIONS COMPRISING A SYNERGISTIC CHALCONE TELLURIS BIOTECH INDIA PRIVATE LTD (IN) 2025-10-22 EP disclosed
US-11369111-B2 Synergistic composition of nematicide comprising of chalcones TELLURIS BIOTECH INDIA PRIVATE LIMITED (IN) 2022-06-28 US disclosed
US-11369111-B2 Synergistic composition of nematicide comprising of chalcones TELLURIS BIOTECH INDIA PRIVATE LIMITED (IN) 2022-06-28 US disclosed
EP-3618630-B1 A SYNERGISTIC COMPOSITION OF NEMATICIDE COMPRISING OF CHALCONES TELLURIS BIOTECH INDIA PRIVATE LTD (IN) 2022-05-25 EP disclosed
EP-3618630-B1 A SYNERGISTIC COMPOSITION OF NEMATICIDE COMPRISING OF CHALCONES TELLURIS BIOTECH INDIA PRIVATE LTD (IN) 2022-05-25 EP disclosed
US-20210195896-A1 A SYNERGISTIC COMPOSITION OF NEMATICIDE COMPRISING OF CHALCONES TELLURIS BIOTECH INDIA PRIVATE LIMITED (IN) 2021-07-01 US disclosed
US-20210195896-A1 A SYNERGISTIC COMPOSITION OF NEMATICIDE COMPRISING OF CHALCONES TELLURIS BIOTECH INDIA PRIVATE LIMITED (IN) 2021-07-01 US disclosed
US-10925286-B2 Synergistic chalcone containing composition of a nematicide TELLURIS BIOTECH INDIA PRIVATE LIMITED (IN) 2021-02-23 US disclosed
US-10925286-B2 Synergistic chalcone containing composition of a nematicide TELLURIS BIOTECH INDIA PRIVATE LIMITED (IN) 2021-02-23 US disclosed
US-20200236948-A1 A SYNERGISTIC CHALCONE CONTAINING COMPOSITION OF A NEMATICIDE TELLURIS BIOTECH INDIA PRIVATE LIMITED (IN) 2020-07-30 US disclosed
US-20200236948-A1 A SYNERGISTIC CHALCONE CONTAINING COMPOSITION OF A NEMATICIDE TELLURIS BIOTECH INDIA PRIVATE LIMITED (IN) 2020-07-30 US disclosed
CN-110678074-A Synergistic chalcones containing nematicide compositions 特鲁里斯生物科技印度私人有限公司 2020-01-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210195896-A1 A SYNERGISTIC COMPOSITION OF NEMATICIDE COMPRISING OF CHALCONES CYP51A1, CASP7, CNN2 AR 3539/4885NPC1 413/4885RAB9A 2608/4885
US-20200236948-A1 A SYNERGISTIC CHALCONE CONTAINING COMPOSITION OF A NEMATICIDE CASP4, NOTCH4, IL4 AR 4266/4885NPC1 3166/4885RAB9A 4614/4885
US-10925286-B2 Synergistic chalcone containing composition of a nematicide CASP4, NOTCH4, IL4 AR 3971/4885NPC1 2721/4885RAB9A 4649/4885
US-11369111-B2 Synergistic composition of nematicide comprising of chalcones CYP51A1, IL17A, CASP7 AR 3259/4885NPC1 462/4885RAB9A 2670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.